argenx SE (ARGX.BR)

EUR 526.4

(-0.23%)

Total Liabilities Summary of argenx SE

argenx SE's latest annual total liabilities in 2023 was 402.79 Million EUR , up 25.65% from previous year.
argenx SE's latest quarterly total liabilities in 2024 Q2 was 534.31 Million EUR , down 0.0% from previous quarter.
argenx SE reported annual total liabilities of 320.56 Million USD in 2022, up 1.43% from previous year.
argenx SE reported annual total liabilities of 316.05 Million USD in 2021, down -47.91% from previous year.
argenx SE reported quarterly total liabilities of 534.31 Million EUR for 2024 Q2, down 0.0% from previous quarter.
argenx SE reported quarterly total liabilities of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Total Liabilities Chart of argenx SE (2023 - 2010)

Historical Annual Total Liabilities of argenx SE (2023 - 2010)

Year	Total Liabilities	Total Liabilities Growth
2023	402.79 Million EUR	25.65%
2022	320.56 Million USD	1.43%
2021	316.05 Million USD	-47.91%
2020	606.75 Million EUR	41.58%
2019	428.56 Million EUR	835.17%
2018	45.82 Million EUR	47.05%
2017	31.16 Million EUR	-30.11%
2016	44.59 Million EUR	369.65%
2015	9.49 Million EUR	-7.36%
2014	10.24 Million EUR	124.36%
2013	4.56 Million EUR	-27.24%
2012	6.27 Million EUR	55.3%
2011	4.04 Million EUR	99.25%
2010	2.02 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	- USD	-100.0%
2024 Q2	534.31 Million EUR	0.0%
2023 Q3	- USD	-100.0%
2023 Q1	- USD	-100.0%
2023 Q2	335.74 Million USD	0.0%
2023 FY	402.79 Million EUR	25.65%
2023 Q4	444.95 Million USD	0.0%
2022 Q3	- USD	-100.0%
2022 FY	320.56 Million USD	1.43%
2022 Q2	279.01 Million USD	0.0%
2022 Q4	320.56 Million USD	0.0%
2021 Q4	316.05 Million USD	0.0%
2021 FY	316.05 Million USD	-47.91%
2021 Q2	261.08 Million USD	0.0%
2020 Q4	606.75 Million EUR	0.0%
2020 Q2	456.61 Million EUR	0.0%
2020 FY	606.75 Million EUR	41.58%
2019 FY	428.56 Million EUR	835.17%
2019 Q2	390.84 Million EUR	0.0%
2019 Q4	382.59 Million EUR	0.0%
2018 Q2	31.28 Million EUR	0.0%
2018 FY	45.82 Million EUR	47.05%
2018 Q4	45.82 Million EUR	0.0%
2017 FY	31.16 Million EUR	-30.11%
2017 Q4	31.16 Million EUR	0.0%
2017 Q2	40.3 Million EUR	0.0%
2016 Q2	46.64 Million EUR	0.0%
2016 Q4	44.59 Million EUR	0.0%
2016 FY	44.59 Million EUR	369.65%
2015 FY	9.49 Million EUR	-7.36%
2015 Q2	11.59 Million EUR	0.0%
2015 Q4	9.49 Million EUR	0.0%
2014 Q1	3.66 Million EUR	-19.7%
2014 Q4	10.24 Million EUR	0.0%
2014 Q2	14.12 Million EUR	285.0%
2014 FY	10.24 Million EUR	124.36%
2013 Q4	4.56 Million EUR	0.0%
2013 FY	4.56 Million EUR	-27.24%
2012 FY	6.27 Million EUR	55.3%
2011 FY	4.04 Million EUR	99.25%
2010 FY	2.02 Million EUR	0.0%

Peer Total Liabilities Comparison of argenx SE

Name	Total Liabilities	Total Liabilities Difference
Nicox S.A.	31.56 Million EUR	-1176.01%
European Medical Solutions	33.86 Million EUR	-1089.388%
FERMENTALG	19.39 Million EUR	-1976.493%
BioSenic S.A.	32.26 Million EUR	-1148.445%
Celyad Oncology SA	9.97 Million EUR	-3936.863%
Hyloris Pharmaceuticals SA	8.61 Million EUR	-4577.173%
Onward Medical N.V.	25.69 Million EUR	-1467.43%
Oxurion NV	19.73 Million EUR	-1940.931%
PHAXIAM Therapeutics S.A.	25.69 Million EUR	-1467.613%
Financière de Tubize SA	123.65 Million EUR	-225.756%
UCB SA	6.56 Billion EUR	93.864%